Knowledge Insight: How PSA Recombinant Rabbit Monoclonal Antibodies Improve Precision in Prostate Cancer Diagnosis and Treatment
Knowledge Insight: How PSA Recombinant Rabbit Monoclonal Antibodies Improve Precision in Prostate Cancer Diagnosis and Treatment
1. Core Concepts
Prostate-Specific Antigen (PSA) is a serine protease exclusively produced by prostate epithelial cells. It is a gold-standard serum biomarker for prostate tissue evaluation, as its concentration remains very low in healthy individuals but rises significantly in prostate cancer, benign prostatic hyperplasia (BPH), or other pathological conditions.
Clinically, total PSA (TPSA) and free PSA (FPSA) are measured to improve diagnostic accuracy, especially in the gray zone (4.0–10.0 ng/mL) where TPSA alone cannot reliably distinguish benign from malignant conditions.
2. Research Frontiers
Prostate cancer screening and monitoring demand increasingly sensitive and specific detection tools. Current advances focus on:
- High-sensitivity immunoassays for early and recurrent disease detection
- Recombinant antibody engineering for enhanced specificity and stability
- Combined detection of TPSA, FPSA, and FPSA/TPSA ratio
- Development of CLIA, POCT, and IVD platforms for clinical use
- Molecular imaging and liquid biopsy applications
Recombinant rabbit monoclonal antibodies have become the preferred core reagent for high-performance PSA detection.
3. Research Significance
Accurate PSA quantification is critical for:
- Early screening of prostate cancer in high-risk populations
- Differential diagnosis between benign and malignant prostate diseases
- Treatment efficacy evaluation after surgery or radiotherapy
- Early detection of cancer recurrence or metastasis
- Risk stratification and personalized clinical management
High-quality anti‑PSA antibodies directly determine the reliability of clinical decision-making.
4. Technical Principles & Diagnostic Value
Why TPSA and FPSA Ratio Matter
- TPSA: Reflects overall prostate abnormality; >10.0 ng/mL strongly suggests malignancy.
- FPSA: Unbound fraction; lower in prostate cancer patients.
- FPSA/TPSA ratio: Improves discrimination in the gray zone (4–10 ng/mL); cutoff ~0.15 provides high specificity.
Advantages of PSA Recombinant Rabbit Monoclonal Antibodies
- Superior affinity & sensitivity: Enables detection of low-level PSA for post-surgery recurrence monitoring.
- Exceptional specificity: Minimizes cross‑reactivity and background interference.
- Batch-to-batch consistency: Recombinant expression eliminates variability for IVD scalability.
- Epitope specificity: Enables accurate discrimination between FPSA and TPSA.
- Broad platform compatibility: Supports CLIA, ELISA, lateral flow, and IHC.
5. Product Empowerment by ANT BIO PTE. LTD.
ANT BIO PTE. LTD. provides PSA Recombinant Rabbit Monoclonal Antibody (Cat. No. S0B3185) under the Starter product line, designed for high-precision prostate cancer IVD development and research.
Core Product Advantages
表格
|
Core Product Advantages |
|
Superior Pairing Specificity & High Affinity: Targets unique PSA epitopes with excellent pairing performance; higher affinity than conventional antibodies. |
|
Exceptional Batch Uniformity: Strict recombinant expression ensures stable, consistent performance for industrial IVD production. |
|
Excellent Platform Compatibility: Fully validated for CLIA, ELISA, immunochromatography, and protein microarrays. |
|
Pre‑Validated Antibody Pairs: Ready-to-use capture/detection combinations shorten IVD development cycles. |
Applications Across Critical Scenarios
表格
|
Applications Across Critical Scenarios |
|
High-Sensitivity IVD Development: Core reagent for CLIA/TPSA‑FPSA quantitative kits. |
|
POCT Rapid Testing: Suitable for fluorescence immunochromatography and microfluidic systems. |
|
Pathological IHC Staining: Supports histopathological diagnosis and differential identification. |
|
Liquid Biopsy & MRD Monitoring: Enables ultrasensitive detection in CTCs, exosomes, and trace tissues. |
6. Brand Mission
ANT BIO PTE. LTD. is a trusted provider of life science reagents, supporting researchers worldwide with high‑performance antibodies, recombinant proteins, ELISA kits, and general laboratory reagents. We operate three specialized sub‑brands:
- Absin: General reagents, buffers, and assay kits
- Starter: High‑quality antibodies for research and diagnostics
- UA: Recombinant proteins for immunization, validation, and standardization
7. Related Product List
- PSA Recombinant Rabbit Monoclonal Antibody (Starter, S0B3185)
- Matched PSA antibody pairs for IVD development (Starter)
- PSA ELISA kits (Absin)
- Recombinant PSA protein standards (UA)
- Immunoassay supporting reagents (Absin)
Brand Promotion Copy
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
